Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey

Hoste, L.; Soriano-Arandes, A.; Buddingh, E.P.; Whittaker, E.; Belot, A.; Ulloa-Gutierrez, R.; ... ; MIS-C Researchers (2022)

Article / Letter to editor

The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C. (J Pediatr 2022;248:114-8).

• All authors: Hoste, L.; Soriano-Arandes, A.; Buddingh, E.P.; Whittaker, E.; Belot, A.; Ulloa-Gutierrez, R.; Olbrich, P.; Haerynck, F.; MIS-C Researchers
• Date: 2022-09-01
• Journal: The Journal of Pediatrics
• Volume: 248
• Pages: 114 - 118
• DOI: doi:10.1016/j.jpeds.2022.05.028
• Link: https://www.sciencedirect.com/science/article/pii/S0022347622004383?via%...